SCOPUS 정보 검색 플랫폼

Clinical Neurology and Neurosurgery

Volumn 104, Issue 3, 2002, Pages 272-275

Quality of life and cost of multiple sclerosis

(2) Miltenburger, Carolin a Kobelt, Gisela a

a BAYER PHARMA AG (Germany)

Author keywords

Cost; Interferon; Quality of life; Treatment

Indexed keywords

INTERFERON BETA SERINE;

CLINICAL TRIAL; CONFERENCE PAPER; COST; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DRUG EFFICACY; HUMAN; MULTIPLE SCLEROSIS; QUALITY OF LIFE; QUESTIONNAIRE;

CLINICAL TRIALS; COST OF ILLNESS; DISABLED PERSONS; HUMANS; MULTIPLE SCLEROSIS; QUALITY OF LIFE;

EID: 0036078008 PISSN: 03038467 EISSN: None Source Type: Journal
DOI: 10.1016/S0303-8467(02)00051-3 Document Type: Article

Times cited : (56)

References (32)

1
- 0028258794
- How many people in the world have multiple sclerosis?
- (1994) Neuroepidemiology , vol.13 , pp. 107
- Dean, G.¹

2
- 17644441679
- Hochrechnung der Zahl an multiple Skerose erkrankten Patienten in Deutschland
- (2000) Nervenarzt , vol.71 , pp. 288-294
- Hein, T.¹ Hopfenmuller, W.²

3
- 0002063324
- Multiple sclerosis and other demyelinating diseases
- Isselbacher K., Braunwald E., Wilson J. (Eds.), Harrison’s principles of internal medicine, New York: McGraw-Hill
- (1994) , pp. 2281-2294
- Hauser, S.¹

4
- 84991430983
- The IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993;43:655-61

5
- 0008678962
- Intramuscular interferon beta-1 a for disease progression in relapsing multiple sclerosis
- (1996) Ann. Neurol. , vol.39 , pp. 285-294
- Jacobs, L.¹ Cookfair, D.² Rudick, R.³ Herndon, R.⁴ Richert, J.⁵ Salazar, A.⁶ Fischer, J.⁷ Granger, C.⁸ Simon, J.⁹ Alam, J.¹⁰ Bartoszak, D.¹¹ Bourdette, D.¹² Braiman, J.¹³ Brownscheidle, C.¹⁴ Coats, M.¹⁵ Cohan, S.¹⁶ Dougherty, D.¹⁷ Kinkel, R.¹⁸ Mass, M.¹⁹ Munschauer F. III²⁰ more..

6
- 84991429698
- The PRISMS Study Group. Randomised double-blind placebo controlled study of interferon beta-1 a in relapsing/remitting multiple sclerosis. Lancet 998;352:1498-504

7
- 84991411499
- The IFNB Multiple Sclerosis Study Group, Interferon beta-1b delays progression of disability in secondary progressive multiple sclerosis: Results of a European multicentre randomised study. Lancet 1998:1491-7

8
- 0031038932
- Interferon-b in multiple sclerosis. Can we control its costs?
- (1997) PharmacoEconomics , vol.11 , pp. 210-215
- Tolley, K.¹ Whynes, D.²

9
- 0035116858
- Health-related quality of life (Hr-QoL) and regulatory issues. An assessment of the European Agency for the Evaluation of Medicinal Product-s (EMEA) recommendations on the use of Hr-QoL measures in drug approval
- (2001) PharmacoEconomics , vol.19 , pp. 187-195
- Apolone, G.¹ De Carli, G.² Brunetti, M.³ Garattini, S.⁴

10
- 84991428337
- Multiple sclerosis, London, UK: Office of Health Economics
- (1987)
- O'Brien, B.¹

11
- 0029814544
- The economics of multiple sclerosis: a cost of illness study
- (1996) Br. J. Med. Econ. , vol.10 , pp. 99-118
- Blumhardt, L.¹ Wood, C.²

12
- 0029619025
- The cost of multiple sclerosis
- (1995) Br. J. Med. Econ. , vol.8 , pp. 181-193
- Holmes, J.¹ Madgwick, T.² Bates, D.³

13
- 0031948456
- The economic cost of multiple sclerosis in Sweden in 1994
- (1998) PharmacoEconomics , vol.13 , pp. 597-606
- Henrikssson, F.¹ Jonsson, B.²

14
- 0029874173
- Impairment, disability and handicap in multiple sclerosis. A cross-sectional study in More and Romsdal County, Norway
- (1996) J. Neurol. , vol.243 , pp. 337-344
- Midgard, R.¹ Riise, T.² Nyland, H.³

15
- 84991415384
- The Canadian Burden of Illness Study Group. Burden of illness of multiple sclerosis: Part I-cost of illness; Part II: quality of life. Can J Neurol Sci 1998;23-30:31-8

16
- 0031812974
- A cost-utility analysis of interferon beta for multiple sclerosis
- (1998) Health Technol. Assess. , vol.2 , Issue.4
- Parkin, D.¹ McNamee, P.² Jacoby, A.³ Miller, P.⁴ Thomas, S.⁵ Bates, D.⁶

17
- 0031947429
- The Cost of MS Study Group. Economic evaluation of multiple sclerosis in the UK, Germany and France
- (1998) PharmacoEconomics , vol.13 , pp. 607-622
- Murphy, N.¹ Confavreux, C.² Haas, J.³ Koenig, N.⁴ Roullet, E.⁵ Sailer, M.⁶ Swash, M.⁷ Young, C.⁸ Merot, J.⁹

18
- 0031792664
- A comprehensive assessment of the cost of multiple sclerosis in the United States
- (1998) Multiple Sclerosis , vol.4 , pp. 419-425
- Whetten-Goldstein, K.¹ Sloan, F.² Goldstein, L.³ Kulas, E.⁴

19
- 84991411555
- Upmeier H, Miltenburger C. The Cost of Multiple Sclerosis in Germany-A Top Down Analysis. ISTAHC 2000, Den Haag, The Netherlands, June 18-21: Poster 153

20
- 0026709310
- Economic status of families living with multiple sclerosis
- (1992) Int. J. Rehabil. Res. , vol.15 , pp. 209-218
- Catanzaro, M.¹ Weinert, C.²

21
- 0035126067
- Costs, quality of life and disease severity in multiple sclerosis. A cross-sectional study in Sweden
- (2001) Eur. J. Neurol. , vol.8 , pp. 27-35
- Henriksson, F.¹ Fredrikson, S.² Masterman, T.³ Jonsson, B.⁴

22
- 84991411638
- Kobelt G, Lindgren P, Parkin D, Francis D, Johnson M, Bates D, Jonsson B. Costs and quality of life in multiple sclerosis. A cross-sectional observational study in the United Kingdom. Stockholm: Stockholm School of Economics, 2000: EFI Research Report 398

23
- 84991414806
- Kobelt G, Lindgren P, Smala A, Bitsch A, Haupts M, Kolmel H, Konig N, Rieckmann P, Zettl U. the German Cost of MS Study Group. Costs and quality of life in multiple sclerosis. A cross-sectional study in Germany. HEPAC 2001;2;60-8

24
- 84991427960
- EuroQoL Group. EuroQoL-a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208

25
- 0029000541
- A health-related quality of life measure for multiple sclerosis
- (1995) Qual. Life Res. , vol.4 , pp. 187-200
- Vickery, B.¹ Hays, R.² Harooni, R.³ Myers, L.⁴ Ellison, G.⁵

26
- 84991422257
- MSQLI Multiple Sclerosis Quality of Life Inventory: A user’s manual, National MS Society
- (1997)
- Ritvo, P.¹ Fisher, J.² Miller, D.³ Andrews, H.⁴ Paty, D.⁵ LaRocca, N.⁶

27
- 8944222564
- The validation of the Functional Assessment in Multiple Sclerosis questionnaire
- (1996) Neurology , vol.47 , pp. 129-139
- Cella, D.¹ Dinen, K.² Amason, B.³ Reder, A.⁴ Webster, K.⁵ Karabatsos, B.⁶ Chang, C.⁷ Lloyd, S.⁸ Mo, F.⁹ Stewart, J.¹⁰ Stefoski, D.¹¹

28
- 0029967873
- Impact of aerobic training on fitness and quality of life in multiple sclerosis
- (1996) Ann. Neurol. , vol.39 , pp. 432-441
- Petajan, J.¹ Gappmaier, E.² White, A.³ Spencer, M.⁴ Mino, L.⁵ Hicks, R.⁶

29
- 1542322334
- Health-related quality of life in people with multiple sclerosis undergoing inpatient rehabilitation
- (1996) J. Neurol. Rehab. , vol.10 , pp. 185-194
- Freeman, J.¹ Langdon, D.² Hobart, J.³ Thompson, A.⁴

30
- 0019827980
- The Sickness Impact Profile: Development and final revision of a health status measure
- (1981) Med. Care , vol.19 , pp. 787-805
- Bergner, M.¹ Bobbit, R.² Carter, W.³ Gibson, B.⁴

31
- 84991411127
- The Functional Limitations Profile may be a valid, reliable and sensitive measure of disability in multiple sclerosis
- (1995) J. Neurol. , vol.42 , pp. 1-8
- Hutchinson, J.¹ Hutchinson, M.²

32
- 84991427613
- Freeman J, Thompson A, Fitzpatrick R, Hutchinson M, Miltenburger C, Beckmann K, Dahlke F, Kappos L, Polman C, Pozzilli C and the European Study Group on Interferon-beta-1b in Secondary Progressive MS. Interferon-beta-1b in the treatment of secondary progressive MS. Impact on quality of life. Neurology 2001;57:1870-5

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.